Pfizer Begins Trials of Omicron Booster
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
More from Massachusetts Business
Boston Business Journal
Petri Dish: Boston Scientific CFO retires; Biotech undergoes 1-for-20 reverse stock split
Massachusetts Business
•
Apr 24, 2025
Massachusetts Lawyers Weekly
Trump administration freezes $2.2 billion in grants to Harvard
Massachusetts Business
•
Apr 15, 2025
Massachusetts Lawyers Weekly
Judge will prevent end of humanitarian parole for people from 4 countries
Massachusetts Business
•
Apr 14, 2025
Massachusetts Lawyers Weekly
Social Security lists thousands of living immigrants as dead to prompt them to leave, AP sources say
Massachusetts Business
•
Apr 14, 2025
Massachusetts Lawyers Weekly
Plea valid despite lack of jury-trial warning
Massachusetts Business
•
Apr 14, 2025
Massachusetts Lawyers Weekly
President: CBS, '60 Minutes' should 'pay a big price' for going after him
Massachusetts Business
•
Apr 14, 2025
Banker and Tradesman
M&T Ups Ratio of Money Set Aside for Troubled Loans
Massachusetts Business
•
Apr 14, 2025
Banker and Tradesman
New Roslindale Zoning Expands Multifamily Possibilities
Massachusetts Business
•
Apr 14, 2025